DH8-31717-33327
4 vaccinations
4 coded responses
45 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 070 / NJ
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-24
Registered in v-safe
-
2021-02-24
Dose 1 — Moderna
- 2021-02-24
-
2021-02-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · Fever · NoneAdult check-in
-
2021-02-26
Survey response — days 1–6 daily, dose 1MedDRA: Injection site erythema — Feeling: Good · Site: RednessFree text: Redness at injection site remains significantMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
-
2021-03-10
Survey response — day 14, dose 1MedDRA: Injection site discolouration, Injection site erythema, Injection site induration, Injection site rash, Injection site warmth — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I developed vaccine arm on the 7th day after my shot - I had a red rash in a circle around the injection site, the skin was hot to the touch and relatively hard. I had to get a prescription strength cortisone. There is still some discoloration.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-10
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-17
-
2021-03-24
Dose 2 — Moderna
- 2021-03-24
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-06-23
- 2021-09-22
-
2021-10-22
Dose 3 — Moderna
- 2021-10-29
- 2021-11-05
- 2021-11-14
- 2021-11-19
- 2021-11-28
-
2021-12-03
Survey response — day 42, dose 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend schoolFree text: Common coldMedDRA releases: 2024-11 · check-in free text available
-
2021-12-13
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-01-21
-
2022-04-22
Survey response — 6 months, dose 3MedDRA: Abortion spontaneous, COVID-19, Office visit, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Pregnancy and miscarriage Covid infection · Healthcare visit (other): Visit with OB GynMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-25
-
2022-10-15
Dose 4 — Moderna
- 2022-10-16
- 2022-10-17
- 2022-10-18
- 2022-10-19
- 2022-10-20
- 2022-10-21
- 2022-10-29
- 2022-11-05
- 2022-11-14
- 2022-11-26
- 2023-01-14
- 2023-04-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-24 | Moderna | |
| 2 | 2021-03-24 | Moderna | |
| 3 | 2021-10-22 | Moderna | No |
| 4 | 2022-10-15 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-10 | Successful 2021-12-13 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-04-22 | Unsuccessful |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): Redness at injection site remains significant
Release 5 — day 14, dose 1
Symptoms: I developed vaccine arm on the 7th day after my shot - I had a red rash in a circle around the injection site, the skin was hot to the touch and relatively hard. I had to get a prescription strength cortisone. There is still some discoloration.
Release 10 — day 42, dose 3
Symptoms: Common cold
Release 11 — 6 months, dose 3
Symptoms: Pregnancy and miscarriage Covid infection
Healthcare visit (other): Visit with OB Gyn
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Abortion spontaneous | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Injection site discolouration | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site induration | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release